# FDA Inspection 1320962 - Rosemont Pharmaceuticals Ltd. - April 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/rosemont-pharmaceuticals-ltd/0304362d-9852-45c2-8c57-33e40126c11b
Source feed: FDA_Inspections

> FDA Inspection 1320962 for Rosemont Pharmaceuticals Ltd. on April 24, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1320962
- Company Name: Rosemont Pharmaceuticals Ltd.
- Inspection Date: 2026-04-24
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1113598 - 2019-02-08](https://www.keypedia.com/records/fda_inspections/rosemont-pharmaceuticals-ltd/70b4b793-4928-4e2d-9649-ad634b0033b9)
- [FDA Inspection 906518 - 2014-12-12](https://www.keypedia.com/records/fda_inspections/rosemont-pharmaceuticals-ltd/1201486e-97d0-4ba1-a281-e682d708d41b)
- [FDA Inspection 753983 - 2011-10-13](https://www.keypedia.com/records/fda_inspections/rosemont-pharmaceuticals-ltd/e8f91322-c7c1-44d5-bf5b-be4e41c4c482)

Company: https://www.keypedia.com/companies/rosemont-pharmaceuticals-ltd/35334ad4-18d1-46db-9772-a739304d5c1b

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8